These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 22537728

  • 1. Child and adolescent depression intervention overview: what works, for whom and how well?
    Maalouf FT, Brent DA.
    Child Adolesc Psychiatr Clin N Am; 2012 Apr; 21(2):299-312, viii. PubMed ID: 22537728
    [Abstract] [Full Text] [Related]

  • 2. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
    March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J.
    Arch Gen Psychiatry; 2007 Oct; 64(10):1132-43. PubMed ID: 17909125
    [Abstract] [Full Text] [Related]

  • 3. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
    March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J, Treatment for Adolescents With Depression Study (TADS) Team.
    JAMA; 2004 Aug 18; 292(7):807-20. PubMed ID: 15315995
    [Abstract] [Full Text] [Related]

  • 4. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
    Cox GR, Callahan P, Churchill R, Hunot V, Merry SN, Parker AG, Hetrick SE.
    Cochrane Database Syst Rev; 2012 Nov 14; 11():CD008324. PubMed ID: 23152255
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.
    Vitiello B, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller MB, Birmaher B, Ryan ND, Kennard B, Mayes TL, DeBar L, Lynch F, Dickerson J, Strober M, Suddath R, McCracken JT, Spirito A, Onorato M, Zelazny J, Porta G, Iyengar S, Brent DA.
    J Clin Psychiatry; 2011 Mar 14; 72(3):388-96. PubMed ID: 21208583
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.
    Health Technol Assess; 2008 May 14; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [Abstract] [Full Text] [Related]

  • 12. Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial.
    Goodyer I, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.
    BMJ; 2007 Jul 21; 335(7611):142. PubMed ID: 17556431
    [Abstract] [Full Text] [Related]

  • 13. Predicting response to cognitive therapy and interpersonal therapy, with or without antidepressant medication, for major depression: a pragmatic trial in routine practice.
    Huibers MJ, van Breukelen G, Roelofs J, Hollon SD, Markowitz JC, van Os J, Arntz A, Peeters F.
    J Affect Disord; 2014 Jan 21; 152-154():146-54. PubMed ID: 24060588
    [Abstract] [Full Text] [Related]

  • 14. The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks.
    March J, Silva S, Vitiello B, TADS Team.
    J Am Acad Child Adolesc Psychiatry; 2006 Dec 21; 45(12):1393-403. PubMed ID: 17135984
    [Abstract] [Full Text] [Related]

  • 15. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
    Davey CG, Chanen AM, Hetrick SE, Cotton SM, Ratheesh A, Amminger GP, Koutsogiannis J, Phelan M, Mullen E, Harrison BJ, Rice S, Parker AG, Dean OM, Weller A, Kerr M, Quinn AL, Catania L, Kazantzis N, McGorry PD, Berk M.
    Lancet Psychiatry; 2019 Sep 21; 6(9):735-744. PubMed ID: 31371212
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Continued Effectiveness of Relapse Prevention Cognitive-Behavioral Therapy Following Fluoxetine Treatment in Youth With Major Depressive Disorder.
    Emslie GJ, Kennard BD, Mayes TL, Nakonezny PA, Moore J, Jones JM, Foxwell AA, King J.
    J Am Acad Child Adolesc Psychiatry; 2015 Dec 21; 54(12):991-8. PubMed ID: 26598474
    [Abstract] [Full Text] [Related]

  • 18. Adjunctive sleep medications and depression outcome in the treatment of serotonin-selective reuptake inhibitor resistant depression in adolescents study.
    Shamseddeen W, Clarke G, Keller MB, Wagner KD, Birmaher B, Emslie GJ, Ryan N, Asarnow JR, Porta G, Brent DA.
    J Child Adolesc Psychopharmacol; 2012 Feb 21; 22(1):29-36. PubMed ID: 22251024
    [Abstract] [Full Text] [Related]

  • 19. Symptom clusters in adolescent depression and differential response to treatment: a secondary analysis of the Treatment for Adolescents with Depression Study randomised trial.
    Bondar J, Caye A, Chekroud AM, Kieling C.
    Lancet Psychiatry; 2020 Apr 21; 7(4):337-343. PubMed ID: 32199509
    [Abstract] [Full Text] [Related]

  • 20. Annual Research Review: Defining and treating pediatric treatment-resistant depression.
    Dwyer JB, Stringaris A, Brent DA, Bloch MH.
    J Child Psychol Psychiatry; 2020 Mar 21; 61(3):312-332. PubMed ID: 32020643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.